<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TNV5PS3" height="0" width="0" style="display:none;visibility:hidden">

Learning Lounge

Karius_Pickup-logo_Final-01-1 Study: Pneumonia in the ImmunoCompromised - Use of the Karius Test® for the Detection of Undiagnosed Pathogens

Pneumonia is a common infectious cause of morbidity and mortality in patients with hematologic malignancies and those post hematopoietic cell transplantation (HCT). The PICKUP study, a multi-center, prospective study, interrogates this population for the etiology of pneumonia by comparing the performance of the Karius Test to the adjudicated Standard of Care (SOC). During this presentation, results will be shared on the additive diagnostic value of the Karius Test when used in conjunction with SOC for the diagnosis of suspected pneumonia.

Thomas L Holland, MD

Assistant Professor of Medicine - Duke University School of Medicine

*This program is sponsored by Karius and CME credit is not available for this event.

Abstracts & Posters

Poster #544
PICKUP: Pneumonia in the ImmunoCompromised - Use of the Karius Test for Detection of Undiagnosed Pathogens

Presenting Author: Stephen Bergin, MD, PhD - Duke University

Thursday, October 20 | 12:15 pm - 1:30 pm ET | Hall B + C

Poster #327
Understanding Current Clinical Scenarios for Plasma Microbial Cell-free DNA Diagnostic Testing Toward Informing Diagnostic Stewardship

Presenting Author: Constance Lau, MPH - Karius

Thursday, October 20 | 12:15 pm - 1:30 pm ET | Hall B+C

Poster #546
Resolution of a Cluster of Travel-Associated Leptospira santarosai Infection in Four Adolescents by Plasma Microbial Cell-Free DNA Detection with the Karius Test®

Presenting Author: Hai Nguyen-Tran, MD - Children’s Hospital Colorado

Thursday, October 20 | 12:15 pm - 1:30 pm ET | Hall B+C

Poster #1342
Serial Microbial Cell-Free DNA Next Generation Sequencing (NGS) As A Means of Diagnosis and Monitoring of Clinical Response To Treatment Of Invasive Fungal Infections (IFI) In Immunocompromised Pediatric Patients

Presenting Author: Negar Ashouri, MD - CHOC Children's Hospital

Friday, October 21 | 12:15 pm - 1:30 pm ET | Hall B+C

Evening Reception



PICKUP the Conversation with Karius at IDWeek 2022

Come meet the Karius team, learn more about our latest multi-center PICKUP Study, and converse with fellow clinicians using the Karius Test in their clinical practice. 

*hors d'oeuvers and drinks will be served

Stay up-to-date with Karius

Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events.


What is the Karius Test?

The Karius Test is a non-invasive liquid biopsy needing only a single blood sample to rapidly detect over 1,000 pathogens causing both deep-seated and bloodstream infections.
1 blood sample
Vector Smart Object (1)
1-day processing
Vector Smart Object (2)
1000+ pathogens

*The Karius Test® was developed and its performance characteristics determined by Karius. This test has not been cleared or approved by the FDA, nor is it required to be. The Karius laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited by the College of American Pathologists (CAP) to perform high-complexity clinical laboratory testing.